Clinical Trial - Radiolabeled Glass Beads in Treating Patients - Liver Cancer

Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Using radiolabeled glass beads to kill tumor cells may be effective treatment for liver cancer that cannot be removed by surgery.

 

Study Type: Observational
Estimated Enrollment: 500 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Humanitarian Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
Actual Study Start Date: December 2004
Estimated Primary Completion Date: January 2020
Estimated Study Completion Date: January 2021

 

Contact

Contact: Clinical Trials Office – Robert H. Lurie Comprehensive Cancer    312-695-1301    cancertrials@northwestern.edu   

 

ClinicalTrials.gov Identifier: NCT00530010

 

For enrollment please visit www.clinicaltrials.gov.

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.